)
Visual24 Oct 2025
The rise of Alphabet
PharmaLundensis (PHAL) investor relations material
PharmaLundensis Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary21 Aug, 2025
Executive summary
Net sales remained at 0 SEK for both the six-month and three-month periods compared to the same periods last year.
Net loss after financial items increased to -3,521,132 SEK for six months and -2,074,093 SEK for three months, both worsening year-over-year.
Equity ratio as of June 30, 2025, was 37%.
Recent share issue raised approximately 3.13 million SEK, providing operational funding into next year.
Focus remains on demonstrating and selling the new Förevaporeringsenheten and optimizing the Phal-501 synthesis for clinical trials.
Financial highlights
Net loss after financial items for six months: -3,521,132 SEK (vs. -1,522,939 SEK year-over-year).
Net loss after financial items for three months: -2,074,093 SEK (vs. -351,221 SEK year-over-year).
Earnings per share for six months: -0.07 SEK (vs. -0.04 SEK year-over-year).
Earnings per share for three months: -0.04 SEK (vs. -0.01 SEK year-over-year).
No dividend for 2024; all profits retained.
Outlook and guidance
Capital from the summer share issue is expected to fund operations into next year, but not cover all outstanding debt.
Demonstrations of the Förevaporeringsenheten are planned for autumn, with potential sales to improve financial position.
Ongoing evaluation of new funding options for the pharmaceutical project, including partnerships or spin-offs.
Cash runway beyond early next year?
Förevaporeringsenhet sales targets for autumn?
Drug project financing options timeline?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next PharmaLundensis earnings date
Q3 202520 Nov, 2025
Next PharmaLundensis earnings date
Q3 202520 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
PharmaLundensis AB is a Sweden-based biotechnology company focused on developing treatments and solutions for respiratory diseases. The company specializes in research aimed at addressing chronic obstructive pulmonary disease (COPD) and related conditions. In addition to its pharmaceutical development activities, PharmaLundensis explores environmentally friendly methods for reducing medical waste and chemical emissions in healthcare. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage